• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Bay Area BioEconomy Initiative appoints Pablo Cagnoni to steering committee

Bay Area BioEconomy Initiative appoints Pablo Cagnoni to steering committee

September 12, 2014
CenterWatch Staff

The Bay Area BioEconomy Initiative (BAB) has named Pablo J. Cagnoni, M.D., president of Onyx Pharmaceuticals, to its steering committee. Onyx, an Amgen subsidiary, is engaged in the development and commercialization of innovative therapies to improve the lives of people with cancer.

The Bay Area BioEconomy Initiative, which brings together the biotech industry, universities, investors, medical centers, health insurers, the technology sector and government, has established three strategic imperatives to improve human health: increasing efficiency in clinical trials; accelerating the timeline of drug discovery, development and diagnosis in areas of significant unmet medical need; and expediting the implementation of innovative technological advances into the everyday practice of medicine.

The Bay Area BioEconomy Initiative steering committee represents members, Bay Area institutions and companies and other stakeholders when making major decisions for the initiative. It is responsible for creating and implementing policies, activities and events that foster innovation and collaboration to strengthen the Bay Area BioEconomy. The steering committee also represents Bay Area BioEconomy Initiative to the community.

Cagnoni currently is president of Onyx Pharmaceuticals, where he has global accountability for product development and commercial strategy for the Onyx portfolio. He joined Onyx in March 2013 as executive vice president, global R&D and technical operations and was named president in October 2013, when Onyx became a subsidiary of Amgen.

Cagnoni previously was senior vice president and global head of clinical development at Novartis Oncology, senior vice president and chief medical officer at Allos Therapeutics and, prior to that, was chief medical officer of OSI Pharmaceuticals.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing